Brendan Walsh - Feb 3, 2023 Form 4 Insider Report for MAXLINEAR, INC (MXL)

Role
VP, Product Line Marketing
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Stock symbol
MXL
Transactions as of
Feb 3, 2023
Transactions value $
-$1,093,646
Form type
4
Date filed
2/7/2023, 08:48 PM
Previous filing
Feb 3, 2023
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Award $0 +5.69K +3.46% $0.00 170K Feb 3, 2023 Direct F1
transaction MXL Common Stock Tax liability -$127K -3.27K -1.92% $38.87 167K Feb 6, 2023 Direct F2
transaction MXL Common Stock Award $0 +23.1K +13.84% $0.00 190K Feb 6, 2023 Direct F3
transaction MXL Common Stock Tax liability -$484K -12.5K -6.55% $38.87 178K Feb 6, 2023 Direct
transaction MXL Common Stock Award $0 +15.4K +8.67% $0.00 193K Feb 6, 2023 Direct F3
transaction MXL Common Stock Tax liability -$323K -8.31K -4.3% $38.87 185K Feb 6, 2023 Direct
transaction MXL Common Stock Award $0 +3.81K +2.06% $0.00 189K Feb 6, 2023 Direct F4
transaction MXL Common Stock Tax liability -$79.8K -2.05K -1.09% $38.87 187K Feb 6, 2023 Direct
transaction MXL Common Stock Award $0 +2.54K +1.36% $0.00 189K Feb 6, 2023 Direct F4
transaction MXL Common Stock Tax liability -$53.2K -1.37K -0.72% $38.87 188K Feb 6, 2023 Direct
transaction MXL Common Stock Award $0 +757 +0.4% $0.00 189K Feb 6, 2023 Direct F5
transaction MXL Common Stock Tax liability -$15.8K -407 -0.22% $38.87 188K Feb 6, 2023 Direct
transaction MXL Common Stock Award $0 +505 +0.27% $0.00 189K Feb 6, 2023 Direct F5
transaction MXL Common Stock Tax liability -$10.5K -271 -0.14% $38.87 188K Feb 6, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued to the Reporting Person for the 2022 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 3, 2023.
F2 On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.
F3 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.
F4 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.
F5 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.